F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,086 | -99.9% | 171,911 | -22.4% | 0.00% | -50.0% |
| Q3 2022 | $1,134,000 | +8.2% | 221,511 | +32.3% | 0.00% | +100.0% |
| Q2 2022 | $1,048,000 | +18.6% | 167,411 | -32.8% | 0.00% | 0.0% |
| Q1 2022 | $884,000 | -39.2% | 249,140 | -13.9% | 0.00% | -50.0% |
| Q4 2021 | $1,453,000 | +66.2% | 289,411 | +142.4% | 0.00% | +100.0% |
| Q3 2021 | $874,000 | -30.8% | 119,411 | -18.8% | 0.00% | -50.0% |
| Q2 2021 | $1,263,000 | -15.7% | 147,011 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $1,498,000 | -16.5% | 138,311 | -23.9% | 0.00% | 0.0% |
| Q4 2020 | $1,794,000 | – | 181,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |